Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease

Journal of the American College of Cardiology

Volumn 53, Issue 15, 2009, Pages 1265-1272

  Postorino, Maurizio ^a   Marino, Carmen ^a   Tripepi, Giovanni ^a   Zoccali, Carmine ^a  

^a CNR   (Italy)

Author keywords

body mass index; cardiovascular risk; dialysis; waist circumference; waist hip ratio

Indexed keywords

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ABDOMINAL FAT; AGED; BODY WEIGHTS AND MEASURES; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 63549143777     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.040     Document Type: Article

References (51)

1. Kramer H.J., Saranathan A., Luke A., et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 17 (2006) 1453-1459
2. K/DOQI, National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35 (2000) S1-S140
3. Fouque D., Vennegoor M., ter Wee P., et al. EBPG guideline on nutrition. Nephrol Dial Transplant 22 Suppl 2 (2007) ii45-ii87
4. Degoulet P., Legrain M., Reach I., et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 31 (1982) 103-110
5. Johansen K.L., Young B., Kaysen G.A., and Chertow G.M. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80 (2004) 324-332
6. Kopple J.D., Zhu X., Lew N.L., and Lowrie E.G. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56 (1999) 1136-1148
7. Lowrie E.G., Li Z., Ofsthun N., and Lazarus J.M. Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 62 (2002) 1891-1897
8. Kalantar-Zadeh K., Kopple J.D., Kilpatrick R.D., et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis 46 (2005) 489-500
9. Leavey S.F., McCullough K., Hecking E., Goodkin D., Port F.K., and Young E.W. Body mass index and mortality in "healthier" as compared with "sicker" haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16 (2001) 2386-2394
10. Kalantar-Zadeh K., Block G., Horwich T., and Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 1439-1444
11. Abdulla J., Kober L., Abildstrom S.Z., Christensen E., James W.P., and Torp-Pedersen C. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 29 (2008) 594-601
12. de Mutsert R., Snijder M.B., van der Sman-de Beer F., et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 18 (2007) 967-974
13. Beddhu S., Pappas L.M., Ramkumar N., and Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14 (2003) 2366-2372
14. Honda H., Qureshi A.R., Axelsson J., et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 86 (2007) 633-638
15. Yusuf S., Hawken S., Ounpuu S., et al., INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
16. Thum T., and Anker S.D. Obesity and risk of myocardial infarction: the INTERHEART study. Lancet 367 (2006) 1051-1052
17. Elsayed E.F., Tighiouart H., Weiner D.E., et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 52 (2008) 49-57
18. Fouque D., Kalantar-Zadeh K., Kopple J., et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73 (2008) 391-398
19. Schmidt D.S., and Salahudeen A.K. Obesity-survival paradox-still a controversy?. Semin Dial 20 (2007) 486-492
20. Kwan B.C., and Beddhu S. A story half untold: adiposity, adipokines and outcomes in dialysis population. Semin Dial 20 (2007) 493-497
21. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 854 (1995) 1-452
22. ERA-EDTA Primary Renal Diagnosis Codes & Groupings & Codes for Cause of Death. http://www.srr.scot.nhs.uk/ERA_EDTA/ERA_EDTA_PRD_Codes_Deaths.pdf Accessed February 9, 2009.
23. Szklo M., and Nieto F.J. Chapter 7: stratification and adjustment: multivariate analysis in epidemiology. Epidemiology. Beyond the Basics (2004), Jones and Bartlett Publishers, Sudbury, MA 257-341
24. Haenszel W., Loveland D.B., and Sirken M.G. Lung cancer mortality as related to residence and smoking histories. I. White males. J Natl Cancer Inst 28 (1962) 947-1001
25. The Italian Cardiovascular Epidemiological Observatory. Ital Heart J 5 Suppl (2004) 49s-92s
26. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the "beef"?. Int J Obes (Lond) 31 (2007) 1552-1553
27. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., and Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 (2005) 543-554
28. Ikizler T.A. Resolved: being fat is good for dialysis patients: the Godzilla effect: pro. J Am Soc Nephrol 19 (2008) 1059-1062
29. Kalantar-Zadeh K., Kuwae N., Wu D.Y., et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 83 (2006) 202-210
30. Kakiya R., Shoji T., Tsujimoto Y., et al. Body fat mass and lean mass as predictors of survival in hemodialysis patients. Kidney Int 70 (2006) 549-556
31. Fujino Y., Ishimura E., Okuno S., et al. Annual fat mass change is a significant predictor of mortality in female hemodialysis patients. Biomed Pharmacother 60 (2006) 253-257
32. Bigaard J., Frederiksen K., Tjønneland A., et al. Body fat and fat-free mass and all-cause mortality. Obes Res 12 (2004) 1042-1049
33. Lahmann P.H., Lissner L., Gullberg B., and Berglund G. A prospective study of adiposity and all-cause mortality: the Malmö Diet and Cancer Study. Obes Res 10 (2002) 361-369
34. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006) 666-678
35. Bigaard J., Tjonneland A., Thomsen B.L., Overvad K., Heitmann B.L., and Sorensen T.I. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res 11 (2003) 895-903
36. Lee S.H., Park J.S., Kim W., et al. Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry). Am J Cardiol 102 (2008) 957-965
37. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894 (2000) i-xii 1-253.
38. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
39. Sanches F.M., Avesani C.M., Kamimura M.A., et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 52 (2008) 66-73
40. Canoy D., Boekholdt S.M., Wareham N., et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 116 (2007) 2933-2943
41. Tankó L.B., Bagger Y.Z., Alexandersen P., Larsen P.J., and Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation 107 (2003) 1626-1631
42. Stenvinkel P., and Lindholm B. Resolved: being fat is good for dialysis patients: the Godzilla effect: con. J Am Soc Nephrol 19 (2008) 1062-1064
43. Axelsson J., Rashid Q.A., Suliman M.E., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80 (2004) 1222-1229
44. Zoccali C., and Mallamaci F. Adiponectin and renal disease progression: another epidemiologic conundrum?. Kidney Int 71 (2007) 1195-1197
45. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
46. Mallamaci F., Tripepi G., and Zoccali C. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. J Nephrol 18 (2005) 464-468
47. Axelsson J., Heimburger O., and Stenvinkel P. Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol 151 (2006) 165-174
48. Zoccali C., Mallamaci F., and Tripepi G. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int Suppl 84 (2003) S65-S68
49. McLaughlin T., Abbasi F., Lamendola C., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106 (2002) 2908-2912
50. Societá Italiana di Nefrologia: Registro Italiano Dialisi e Trapianto. http://www.sin-ridt.org/sin-ridt.org.htm Accessed February 9, 2009.
51. Wing R.R., Jeffery R.W., Burton L.R., Thorson C., Kuller L.H., and Folsom A.R. Change in waist-hip ratio with weight loss and its association with change in cardiovascular risk factors. Am J Clin Nutr 55 (1992) 1086-1092